EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

被引：93

作者：

Boyman, O. ^{[1
]}

Kaegi, C. ^{[1
]}

Akdis, M. ^{[2
,3
]}

Bavbek, S. ^{[4
]}

Bossios, A. ^{[5
]}

Chatzipetrou, A. ^{[6
]}

Eiwegger, T. ^{[7
]}

Firinu, D. ^{[8
]}

Harr, T. ^{[9
]}

Knol, E. ^{[10
,11
]}

Matucci, A. ^{[12
]}

Palomares, O. ^{[13
]}

Schmidt-Weber, C. ^{[14
,15
]}

Simon, H-U. ^{[16
]}

Steiner, U. C. ^{[17
]}

Vultaggio, A. ^{[12
]}

Akdis, C. A. ^{[2
,3
]}

Spertini, F. ^{[18
]}

机构：

[1] Univ Zurich, Dept Immunol, Univ Zurich Hosp, CH-8091 Zurich, Switzerland

[2] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland

[3] CK CARE, Davos, Switzerland

[4] Ankara Univ, Dept Pulm Dis, Div Immunol & Allergy, Sch Med, TR-06100 Ankara, Turkey

[5] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Krefting Res Ctr,Dept Internal Med & Nutr, Gothenburg, Sweden

[6] Univ Athens, Allergy Unit D Kalogeromitros, Dept Dermatol & Venerol 2, Attikon Univ Hosp,Med Sch, Athens, Greece

[7] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria

[8] Univ Cagliari, Unit Internal Med Allergy & Clin Immunol, Dept Med Sci M Aresu, Monserrato, Italy

[9] Hop Univ Genev, Specialites Med, Serv Immunol & Allergol, Geneva, Switzerland

[10] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands

[11] Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands

[12] Azienda Osped Univ Careggi, Dept Biomed, Immunoallergol Unit, Florence, Italy

[13] Univ Complutense Madrid, Dept Biochem & Mol Biol, Sch Chem, Madrid, Spain

[14] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany

[15] Helmholtz Ctr Munich, Munich, Germany

[16] Univ Bern, Inst Pharmacol, Bern, Switzerland

[17] Spitalnetz Bern Tiefenau Ziegler, Div Allergol & Clin Immunol, Bern, Switzerland

[18] CHU Vaudois, Div Immunol & Allergy, Lausanne, Switzerland

来源：

ALLERGY | 2015年 / 70卷 / 07期

基金：

瑞士国家科学基金会;

关键词：

allergic rhinitis; asthma; atopic dermatitis; eosinophilic disorders; food allergy; hymenoptera allergy; urticaria; NECROSIS-FACTOR-ALPHA; ANTI-CD20 RITUXIMAB TREATMENT; CHRONIC AUTOIMMUNE URTICARIA; ADAPTIVE IMMUNE-RESPONSES; SEVERE ATOPIC-DERMATITIS; SEVERE PERSISTENT ASTHMA; INDUCED AIRWAY RESPONSES; LONG-TERM SAFETY; ANTI-IGE; MONOCLONAL-ANTIBODY;

D O I：

10.1111/all.12616

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Biologic agents (also termed biologicals or biologics) are therapeutics that are synthesized by living organisms and directed against a specific determinant, for example, a cytokine or receptor. In inflammatory and autoimmune diseases, biologicals have revolutionized the treatment of several immune-mediated disorders. Biologicals have also been tested in allergic disorders. These include agents targeting IgE; T helper 2 (Th2)-type and Th2-promoting cytokines, including interleukin-4 (IL-4), IL-5, IL-9, IL-13, IL-31, and thymic stromal lymphopoietin (TSLP); pro-inflammatory cytokines, such as IL-1, IL-12, IL-17A, IL-17F, IL-23, and tumor necrosis factor (TNF); chemokine receptor CCR4; and lymphocyte surface and adhesion molecules, including CD2, CD11a, CD20, CD25, CD52, and OX40 ligand. In this task force paper of the Interest Group on Biologicals of the European Academy of Allergy and Clinical Immunology, we review biologicals that are currently available or tested for the use in various allergic and urticarial pathologies, by providing an overview on their state of development, area of use, adverse events, and future research directions.

引用

页码：727 / 754

页数：28

共 44 条

[21] Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
Roth-Walter, F.
Adcock, I. M.
Benito-Villalvilla, C.
Bianchini, R.
Bjermer, L.
Caramori, G.
Cari, L.
Chung, K. F.
Diamant, Z.
Eguiluz-Gracia, I.
Knol, E. F.
Jesenak, M.
Levi-Schaffer, F.
Nocentini, G.
O'Mahony, L.
Palomares, O.
Redegeld, F.
Sokolowska, M.
Van Esch, B. C. A. M.
Stellato, C.
ALLERGY, 2024, 79 (05) : 1089 - 1122
[22] Expert consensus document on the use of antiplatelet agents -: The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology
Patrono, C
Bachmann, F
Baigent, C
Bode, C
De Caterina, R
Charbonnier, B
Fitzgerald, D
Hirsh, J
Husted, S
Kvasnicka, J
Montalescot, G
Rodríguez, LAG
Verheugt, F
Vermylen, J
Wallentin, L
EUROPEAN HEART JOURNAL, 2004, 25 (02) : 166 - 181
[23] Cannabis use in adolescents Narrative Review and Position paper of the "Addiction Disorders in Adolescents" task force of the Austrian Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (oGKJP)
Skala, Katrin
Trabi, Thomas
Fuchs, Martin
Goessler, Ralf
Haas-Stockmair, Christian-Wilhelm
Kriechbaumer, Nicole
Leitner, Monika
Ortner, Nora
Reiter, Melanie
Mueller, Christian
Wladika, Wolfgang
NEUROPSYCHIATRIE, 2023, 37 (04) : 175 - 195
[24] Management of opioid use disorders among veterans in subacute rehab: Use of an interdisciplinary task force to address an emerging concern
Hinrichs, Kate L. M.
Sharma, Samata
Thurston, Joe
Sivashanker, Karthik
Chang, Grace H.
SUBSTANCE ABUSE, 2016, 37 (01) : 4 - 6
[25] Recommendation from the Community Preventive Services Task Force for Use of Collaborative Care for the Management of Depressive Disorders
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2012, 42 (05) : 521 - 524
[26] Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Levy-Clarke, Grace
Jabs, Douglas A.
Read, Russell W.
Rosenbaum, James T.
Vitale, Albert
Van Gelder, Russell N.
OPHTHALMOLOGY, 2014, 121 (03) : 785 - U215
[27] The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders
Beaulieu, Serge
Saury, Sybille
Sareen, Jitender
Tremblay, Jacques
Schuetz, Christian G.
McIntyre, Roger S.
Schaffer, Ayal
ANNALS OF CLINICAL PSYCHIATRY, 2012, 24 (01) : 38 - 55
[28] Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
Sokolowska, Milena
Rovati, G. Enrico
Diamant, Zuzana
Untersmayr, Eva
Schwarze, Jurgen
Lukasik, Zuzanna
Sava, Florentina
Angelina, Alba
Palomares, Oscar
Akdis, Cezmi
O'Mahony, Liam
Jesenak, Milos
Pfaar, Oliver
Torres, Maria Jose
Sanak, Marek
Dahlen, Sven-Erik
Woszczek, Grzegorz
ALLERGY, 2022, 77 (08) : 2337 - 2354
[29] Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping:: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN
Carlsen, K. H.
Anderson, S. D.
Bjermer, L.
Bonini, S.
Brusasco, V.
Canonica, W.
Cummiskey, J.
Delgado, L.
Del Giacco, S. R.
Drobnic, F.
Haahtela, T.
Larsson, K.
Palange, P.
Popov, T.
van Cauwenberge, P.
ALLERGY, 2008, 63 (05) : 492 - 505
[30] Exercise-induced asthma, respiratory and allergic disorders in elite athletes:: epidemiology, mechanisms and diagnosis:: Part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN
Carlsen, K. H.
Anderson, S. D.
Bjermer, L.
Bonini, S.
Brusasco, V.
Canonica, W.
Cummiskey, J.
Delgado, L.
Del Giacco, S. R.
Drobnic, F.
Haahtela, T.
Larsson, K.
Palange, P.
Popov, T.
van Cauwenberge, P.
ALLERGY, 2008, 63 (04) : 387 - 403

← 1 2 3 4 5 →